Fredric Manfredsson, PhD, is an associate professor in the Department of Translational Neuroscience at Barrow Neurological Institute. Dr. Manfredsson’s expertise includes gene therapy for Parkinson’s disease and other neurodegenerative diseases. Dr. Manfredsson’s research has focused on understanding the role of the protein alpha-synuclein in both healthy cells and those affected by Parkinson’s disease. His research also emphasizes understanding the symptomology of the disease, with a focus on the treatment of levodopa-induced dyskinesia and nonmotor symptoms experienced by nearly all patients with Parkinson’s disease.
Dr. Manfredsson’s is Chair of the American Society for Gene & Cell Therapy Neurological & Ophthalmological Committee, and Past President of The American Society for Neural Therapy and Repair, and the Society for Neuroscience. Dr. Manfredsson earned his doctorate degree in neuroscience from the University of Florida in Gainesville, where he also completed a postdoctoral fellowship in neuroscience.